Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
News and Events

Featured Stories

Hot information:
Top 10 Global Clinical Research Organizations in 2021| Medicilon Pharmacokinetic Services for First-in-Class Ubiquitination Inhibitor Development| ADC, precision and deep cultivation for targeted drug delivery
Nov 19,2021
Discovery and Optimization of Lead Compounds
Discovery of Lead Compounds Hit to Lead The discovery of lead compounds is the process of turning the "hits” found in screening into "lead compounds” that can be further optimized. The lead compound may be a selected compound or a series of homologs, or it may be a compound derived from literature. However, for high-throughputRead more
More
Discovery and Optimization of Lead Compounds
Nov 19,2021
Injection vs. Oral Solid Preparations
From the perspective of various stages, there are big differences between domestic generic drug injections and oral solid preparations in terms of generic drug consistency evaluation, competition pattern, and overall market size. Domestic sales of injections account for too much From the PDB sample data, injections account for more than 60% of domestic prescription drugRead more
More
Injection vs. Oral Solid Preparations
Nov 19,2021
The Current Situation of Domestic Oral Solid Preparations Industry
Oral solid preparations usually refer to the general term for the preparation of tablets, capsules, granules, etc., after natural medicines are crushed and extracted. This article will briefly introduce the difficulty of evaluating the consistency of generic drugs and the competitive landscape of oral solid preparations. It is Difficult to Evaluate the Consistency of OralRead more
More
The Current Situation of Domestic Oral Solid Preparations Industry
Nov 18,2021
Consistency Evaluation of Oral Solid Preparation
As of May 2019, starting from the formal acceptance of the first conformity evaluation product in 2017, there have been nearly 900 oral solid preparations for conformity evaluation. The dosage forms include tablets, capsules, powders, sustained-release capsules, etc. At present, more than 200 product specifications have passed the consistency evaluation. The consistency evaluation ofRead more
More
Consistency Evaluation of Oral Solid Preparation
Nov 18,2021
Storage Time of Oral Solid Preparations
FDA declaration 3.2.P.3.4 includes three contents. Acceptance criteria and test results of registered batches;Comparison table of equipment and control standards used in registered batches and commercial batches;Intermediate storage information. The contents of the first and second items may be familiar to everyone. Therefore, this article mainly introduces the third item, the key point of intermediateRead more
More
Storage Time of Oral Solid Preparations
Nov 16,2021
Liver Microsome Model of Drug Metabolism Model in Vitro
For those drugs with low metabolic rate, high toxicity, or lack of sensitive detection methods, in vitro drug metabolism studies can eliminate the interference of internal factors and provide reliable theoretical data for the overall experiment. The liver microsomal model is one of the common in vitro models for studying drug metabolism in laboratories. ItRead more
More
Liver Microsome Model of Drug Metabolism Model in Vitro
Nov 16,2021
Basic Parameters and Abbreviations in Pharmacokinetic Tests
Pharmacokinetic Parameters Pharmacokinetic parameters represent the parameters of the mathematical model of the process of drug absorption, distribution, excretion and structural transformation in the body. Absorption Dissolution: the degree to which the drug molecule is dissolved in the digestive tract Bioavailability: the degree of drug absorption Absolute bioavailability Maximum blood concentration (Cmax) Peak time (Tmax)Read more
More
Basic Parameters and Abbreviations in Pharmacokinetic Tests
Nov 16,2021
Pre-clinical Research Escorts the Development of Innovative Drugs
The first challenge in drug development is the pre-clinical research of new drugs, which refers to the chemical synthesis or natural product purification research, drug analysis research, pharmacodynamics, pharmacokinetics, and toxicology that are carried out before the drug enters clinical research. And pharmaceutics research. Preclinical research on new drugs escorts the development of innovative drugs.Read more
More
Pre-clinical Research Escorts the Development of Innovative Drugs
Nov 12,2021
Non-labeled Natural Product Target Identification and Validation
The structure of natural products is complex and rich, with a wide range of biological activities, and is an important source of new drug innovation. According to statistics, nearly half of the drugs approved by the U.S. Food and Drug Administration (FDA) for cancer treatment in the past 30 years Medicines are directly or indirectlyRead more
More
Non-labeled Natural Product Target Identification and Validation
Nov 12,2021
Artificial Intelligence Helps Drug Development
On October 22, 2021, the research group of Academician Hualiang Jiang and Mingyue Zheng from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences published an article Drug target inference by mining transcriptional data using a novel graph convolutional network framework on Protein & Cell. Researchers applied the Twin Spectrogram Convolutional Network (SSGCN).
More
Artificial Intelligence Helps Drug Development